New York City Barely Tests for Virus Variants. Can That Change?
The rate in January was far below the 10 percent recommended by some experts. Now, officials are aiming to put a more robust program in place.
New York City has had an average of more than 5,000 new coronavirus cases a day in recent weeks.Credit.James Estrin/The New York Times
Published Feb. 3, 2021Updated Feb. 9, 2021
In New York City, despite its many major hospitals and research institutions, only about 55 coronavirus cases a day on average last month were sequenced and screened for more contagious variants.
That amounted to just 1 percent of the city’s new cases, a rate far below the 10 percent that some experts say is needed to understand the dynamics of New York’s epidemic at a time when more contagious variants, including some that may blunt the effectiveness of existing vaccines, have led to surges of cases in Britain, Brazil and South Africa.
Day Five of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Identifies Structural Variants that May Predispose to Severe COVID-19 Illness
January 18, 2021 19:00 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
COVID-19 Host Genome Structural Variant (SV) Consortium used Saphyr to identify SVs in severe COVID-19 patients that affect genes involved in immunity, airway mucous, and viral replication
SVs found by several investigators point to a central role for disease severity of the interferon response pathway
Consortium has added investigators from Augusta University, Boston Children’s Hospital, New York Genome Center, Radboud University, Rockefeller University, UC San Diego, Virginia Commonwealth University, and two dozen other institutes from around the world
COVID-19 Host Genome SV Consortium Identifies Structural Variants with Possible Roles in Pathogenesis and Outcomes in Severely Ill COVID-19 Patients Using Bionano’s Saphyr® System First publication from international consortium highlights prowess of Saphyr in identifying large SVs with clinical significance and in COVID-19, an area with great public health implications
January 11, 2021 08:00 ET | Source: Bionano Genomics Bionano Genomics San Diego, California, UNITED STATES
SAN DIEGO, Jan. 11, 2021 (GLOBE NEWSWIRE) Bionano Genomics, Inc. (Nasdaq: BNGO), announced today the first publication from the COVID-19 Host Genome Structural Variant Consortium. The study found that optical genome mapping (OGM) with Bionano’s Saphyr System identified structural variants (SVs) that affect genes in pathways that control immune and inflammatory response, viral reproduction and mucosal function. The authors believe these S
Answer ALS Launches The Data is Here Campaign to Announce the Release of the World s Largest Open Sourced ALS Data Portal
The Answer ALS Data Portal seeks to empower researchers around the globe with the data needed to finally answer ALS
News provided by
Share this article
Share this article
NEW ORLEANS, Jan. 8, 2021 /PRNewswire/ Answer ALS, in cooperation with the Stephen Hawking Foundation, launches The Data is Here campaign on January 8 and on what would have been the famed Theoretical Physicist s 79th birthday. The campaign features a video tribute to Stephen Hawking and his tireless efforts to solve complex universal questions, while living with ALS for over 50 years. Although he and science were unable to unravel the mystery of ALS in his lifetime, the campaign boldly states, At 21, Stephen Hawking was diagnosed with ALS. In 21, we aim to make a breakthrough in his honor. The data is here.
COVID-19 One Year Later: The Biology and the Business
As the world hits the one-year anniversary of COVID-19, GEN looks at the work being done to combat the pandemic
January 8, 2021
As this image shows, the SARS-CoV-2 virion is studded with proteins, one of which is the so-called spike protein. The spike, which consists of two subunits, S1 and S2, took center stage early in the COVID-19 pandemic and has become a key component in the development of vaccines and therapeutics. [Design Cells/Getty Images]
Share
The days are long, but the years are short.” This bittersweet saying, which is often shared with new parents, may apply to everyone who has been living through the COVID-19 pandemic although what we’re experiencing is almost entirely bitter and not at all sweet. Over the past 12 months, SARS-CoV-2, an RNA virus that carries a mere 29,903 nucleotides, has devastated our communities, disabling economies and taking far too many lives. However, as we hit the grim one-year ann